Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas †
Titel:
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas †
Auteur:
Ramanathan, R.K. Goldstein, D. Korn, R.L. Arena, F. Moore, M. Siena, S. Teixeira, L. Tabernero, J. Van Laethem, J.-L. Liu, H. McGovern, D. Lu, B. Von Hoff, D.D.